The CIMESTRA study: intra-articular glucocorticosteroids and synthetic DMARDs in a treat-to-target strategy in early rheumatoid arhtritis

TY - JOUR

T1 - The CIMESTRA study

T2 - intra-articular glucocorticosteroids and synthetic DMARDs in a treat-to-target strategy in early rheumatoid arhtritis

AU - Hetland, Merete L

AU - Hørslev-Petersen, Kim

PY - 2013

Y1 - 2013

N2 - Treatment of early rheumatoid arthritis (RA) include aiming at disease control with early use of methotrexate (MTX) in monotherapy or in combination with glucocorticoids or other disease-modifying drugs (DMARDs). The CIMESTRA study applied an aggressive treatment with DMARD and intra-articular injections of glucocorticoids (i.a. GC) to control disease activity. This paper reviews the results of the five years' study.

AB - Treatment of early rheumatoid arthritis (RA) include aiming at disease control with early use of methotrexate (MTX) in monotherapy or in combination with glucocorticoids or other disease-modifying drugs (DMARDs). The CIMESTRA study applied an aggressive treatment with DMARD and intra-articular injections of glucocorticoids (i.a. GC) to control disease activity. This paper reviews the results of the five years' study.

M3 - Journal article

SN - 0392-856X

VL - 30

SP - S44-9

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

IS - 4 Suppl 73

ER -